Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 11.24% vs 6.85% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 8.29% vs 21.96% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 2.03% vs 67.27% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 8.34% vs 23.42% in Mar 2025
Compare Profit and Loss Results of Jenburkt Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
168.00
178.00
-10.00
-5.62%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
168.00
178.00
-10.00
-5.62%
Expenditure (Ex Depriciation)
Stock Adjustments
-4.00
7.00
-11.00
-157.14%
Raw Materials Consumed
37.00
91.00
-54.00
-59.34%
Power & Fuel Cost
0.00
7.00
-7.00
-100.00%
Employee Cost
49.00
22.00
27.00
122.73%
Operating Expenses
4.00
13.00
-9.00
-69.23%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
19.00
8.00
11.00
137.50%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
2.00
-2.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
125.00
159.00
-34.00
-21.38%
Operating Profit (PBDIT) excl Other Income
43.00
19.00
24.00
126.32%
Other Income
10.00
3.00
7.00
233.33%
Operating Profit (PBDIT)
54.00
22.00
32.00
145.45%
Interest
0.00
3.00
-3.00
-100.00%
Profit before Depriciation and Tax
53.00
18.00
35.00
194.44%
Depreciation
3.00
7.00
-4.00
-57.14%
Profit Before Taxation & Exceptional Items
50.00
11.00
39.00
354.55%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
46.00
11.00
35.00
318.18%
Provision for Tax
11.00
2.00
9.00
450.00%
Profit After Tax
34.00
9.00
25.00
277.78%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
162.00
102.00
60.00
58.82%
Profit Available for appropriations
197.00
112.00
85.00
75.89%
Appropriations
197.00
112.00
85.00
75.89%
Equity Dividend (%)
207%
10%
197.00
Earnings Per Share
78.71
6.94
71.77
1,034.15%
Profit And Loss - Net Sales
Net Sales 168.74 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.24% vs 6.85% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 43.74 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 8.29% vs 21.96% in Mar 2025
Profit And Loss - Interest
Interest 0.46 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 2.03% vs 67.27% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 34.74 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 8.34% vs 23.42% in Mar 2025
Footer loading
